XML 40 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2
B. Stock-Based Compensation and Warrants (Details)
3 Months Ended
Sep. 30, 2016
USD ($)
$ / shares
shares
B. Stock-based Compensation And Warrants Details  
Shares Outstanding July 1, 2016 | shares 1,200,000
Shares Granted | shares 0
Shares Exercised | shares 0
Shares Forfeited or expired | shares 0
Shares Outstanding September 30, 2016 | shares 1,200,000
Shares Exercisable September 30, 2016 | shares 1,200,000
Weighted average exercise price per share outstanding July 1, 2016 | $ / shares $ .58
Weighted average exercise price per share Granted | $ / shares 0.00
Weighted average exercise price per share Exercised | $ / shares 0.00
Weighted average exercise price per share Forfeited or expired | $ / shares 0.00
Weighted average exercise price per share Outstanding September 30, 2016 | $ / shares .58
Weighted average exercise price per share Exercisable September 30, 2016 | $ / shares $ 0.58
Weighted average remaining contractual term Outstanding July 1, 2016 2 years 11 days [1]
Weighted average remaining contractual term Outstanding September 30, 2016 1 year 9 months 11 days [1]
Weighted average remaining contractual term Exercisable September 30, 2016 1 year 9 months 11 days [1]
Aggregate Intrinsic Value Outstanding July 1, 2016 $ 0 [2]
Aggregate Intrinsic Value Granted 0 [2]
Aggregate Intrinsic Value Exercised 0 [2]
Aggregate Intrinsic Value Forfeited or expired 0 [2]
Aggregate Intrinsic Value Outstanding September 30, 2016 0 [2]
Aggregate Intrinsic Value Exercisable September 30, 2016 0 [2]
Aggregate fair value outstanding July 1, 2016 273,500 [3]
Aggregate fair value Granted 0 [3]
Aggregate fair value Exercised 0 [3]
Aggregate fair value Forfeited or expired 0 [3]
Aggregate fair value Outstanding September 30, 2016 273,500 [3]
Aggregate fair value Exercisable September 30, 2016 $ 273,500 [3]
[1] Remaining contractual term presented in years.
[2] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing price of the Company's common stock as of September 30, 2016, for those awards that have an exercise price currently below the closing price as of September 30, 2016 of $0.18.
[3] Aggregate Fair Value is calculated using the Black Scholes option pricing model to estimate fair value of stock-based compensation on the date of grant.